Amcham Vietnam

Organizations

OPV Pharmaceutical Joint Stock Company

Click here to contact OPV Pharmaceutical Joint Stock Company

Industry: Pharmaceutical and Medicine (NAICS 3254)

Address:
No. 27, Street 3A
Bien Hoa 2 Industrial Zone
Dong Nai Province
Vietnam
Phone: +84 61 3992 999
Fax: +84 61 3892 344

Activities:

OPV is active in the field of pharmaceuticals, nutritional and personal care products, distributing both its own brands and licensed products of multinationals in Vietnam, OPV also does licensed and contract manufacturing for international companies and Vietnamese distribution firms and has started to export products to other countries.

OPV was established in the 1950s to provide world class pharmaceuticals and nutritional products for Vietnamese people. Over decades, OPV worked closely with leading pharmaceutical and nutritional companies, such as Bayer, Ciba Geigy, Merck, Roche, Sandoz, Upjohn, Warner Lambert and Nestle.

By the 1970’s OPV became a leading pharmaceutical company in Vietnam and built the largest pharmaceutical plant in the country, now part of Pharmaceutical factory No 24, and the powder milk plant Dielac in a joint venture with Nestle, now one factory of Vinamilk company.

Since 1993, OPV has resumed its operations in the pharmaceutical field in Vietnam with the marketing of high quality pharmaceutical and nutritional products, medical equipment and healthcare products, which are manufactured in the USA and Europe.

Description:

In 2003, OPV completed a high quality pharmaceutical factory in Bien Hoa Industrial Zone 2 under a 100% foreign-invested project of US$ 20 million. This factory is producing a wide range of pharmaceuticals, IV solutions, nutritional products and consumer healthcare brands with world-class quality in all major dosage forms (tablets, capsules, sachets, injectables, oral liquids, creams and ointments). The production facilities are capable of meeting contract and licensed manufacturing needs of multinationals in
Vietnam. Since 2005, the factory’s WHO-GMP standard has been certified by the Ministry of Health.

In 2003, OPV Pharmaceutical Company formed a joint venture with Otsuka Pharmaceutical Company from Japan for the production and marketing of IV solutions and amino acids. In 2005, after over a year of quality audits, the OPV factory was approved by GlaxoSmithKline, a leading pharmaceutical company of the world, to produce a number of GSK products, and the two companies have signed a manufacturing cooperation agreement. OPV has also signed manufacturing agreements with UCB and Chemo Iberica, two European pharmaceutical companies.

In July 2007, OPV Pharmaceutical Company was converted into a joint stock company, and it increased its capital with an equity investment from an international investment fund, Tree Line Asia Master Fund.